AI Terminal
ESKEN LIMITED
Remuneration Information • Dec 22, 2021
5145_dirs_2021-12-22_dba6ba65-97d9-4ac5-ad12-2afca52c0313.html
Remuneration Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 4110W
Esken Limited
22 December 2021
22 December 2021
Esken Limited
("Esken" and the "Company")
Director/PDMR Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
LTIP Awards in respect of FY22
Esken has granted long-term incentive awards in respect of the financial year ended 28 February 2022 over its ordinary shares under the Esken Limited Long Term Incentive Plan 2020 (the "LTIP"), as follows:
| Name | Number of shares subject to award |
| Nick Dilworth, Chief Operating Officer (200% of salary) | 4,820,1441 |
| Lewis Girdwood, Chief Financial Officer (200% of salary) | 4,820,1441 |
1 The number of shares comprised in awards have been based on a price for Esken's ordinary shares of 13.9 pence (being the average price in the three-day period leading up to the Remuneration Committee's meeting approving the awards.
As with the awards in respect of the Company's 2021 financial year made in September 2021, the Remuneration Committee of the Company has approved a wholly TSR-based performance measure for these awards on the basis that this would be closely aligned to shareholder interests. The performance targets attached to these awards are linked to an increase in the price of the Company's ordinary shares measured over the Company's 2022, 2023 and 2024 financial years (i.e. from 1 March 2021 to 28 February 2024), subject to a general financial performance underpin, as set out in the table below (with straight-line vesting between these points):
| Vesting | Esken's share price |
| 25% of maximum | a share price of 20.0p at vesting |
| 100% of maximum | a share price of 30.0p at vesting |
In assessing whether or not a particular share price has been achieved the Remuneration Committee will also take in to account the per share value of any dividend paid on ordinary shares during the performance period assuming that the dividend was reinvested into ordinary shares on the ex-dividend date.
Enquiries:
| Esken Limited Charlie Geller, Communications Director C/O Tulchan Communications |
C/O Tulchan Communications |
| Tulchan Communications Olivia Peters/David Allchurch/Giles Kernick |
020 7353 4200 [email protected] |
FY22 LTIP awards
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| (a) | Name | (i) Nick Dilworth (ii) Lewis Girdwood |
|
| 2 | Reason for the notification | ||
| (a) | Position/Status | (ii) Chief Operating Officer (iii) Chief Financial Officer |
|
| (b) | Initial notification / Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| (a) | Name | Esken Limited | |
| (b) | LEI | 213800BINQVRZFKA3E89 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the financial instrument, type of instrument Identification Code |
Ordinary Shares of 10p each in the capital of Esken Limited ISIN: GB00B03HDJ73 |
|
| (b) | Nature of the transaction | Grant of FY22 awards under the Esken Limited Long Term Incentive Plan 2020 | |
| (c) | Price(s) and volume(s) | Price: Nil | Volumes: (i) 4,820,144 (ii) 4,820,144 |
| (d) | Aggregated Information - Aggregated Volume - Price |
N/A | |
| (e) | Date of the Transaction | 21 December 2021 | |
| (f) | Place of the Transaction | Outside a trading venue |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAPAFAFPFFFA